Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clifford V Harding

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|January 27, 2017
<i>Mycobacterium tuberculosis</i> Membrane Vesicles Inhibit T Cell ActivationJaffre J Athman, Obondo J Sande, Sarah G Groft, et al.
Immunology|April 23, 2013
Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammationNicholas T Funderburg, Samantha R Stubblefield Park, Hannah C Sung, et al.
Infection and Immunity|November 17, 2010
Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2Christina L Lancioni, Qing Li, Jeremy J Thomas, et al.
The Journal of Infectious Diseases|February 22, 2012
Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus declineSara J Conry, Qinglai Meng, Gareth Hardy, et al.
Nature Structural & Molecular Biology|August 10, 2010
Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2Michael G Drage, Han-Chun Tsai, Nicole D Pecora, et al.
European Journal of Immunology|February 6, 2014
TLR2 engagement on CD4(+) T cells enhances effector functions and protective responses to Mycobacterium tuberculosisScott M Reba, Qing Li, Sophia Onwuzulike, et al.
Plos One|February 1, 2012
Interferon-alpha administration enhances CD8+ T cell activation in HIV infectionMaura Manion, Benigno Rodriguez, Kathleen Medvik, et al.
Circulation Research|April 15, 2021
COVID-19 and Cardiovascular Disease: From Bench to BedsideMina K Chung, David A Zidar, Michael R Bristow, et al.
Plos One|February 26, 2013
Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markersGareth A D Hardy, Scott Sieg, Benigno Rodriguez, et al.
Infection and Immunity|April 20, 2006
The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytesSaet-Byel Jung, Chul-Su Yang, Ji-Sook Lee, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
Journal of Immunology (Baltimore, Md. : 1950)|January 27, 2017
<i>Mycobacterium tuberculosis</i> Membrane Vesicles Inhibit T Cell ActivationJaffre J Athman, Obondo J Sande, Sarah G Groft, et al.
Immunology|April 23, 2013
Circulating CD4(+) and CD8(+) T cells are activated in inflammatory bowel disease and are associated with plasma markers of inflammationNicholas T Funderburg, Samantha R Stubblefield Park, Hannah C Sung, et al.
Infection and Immunity|November 17, 2010
Mycobacterium tuberculosis lipoproteins directly regulate human memory CD4(+) T cell activation via Toll-like receptors 1 and 2Christina L Lancioni, Qing Li, Jeremy J Thomas, et al.
The Journal of Infectious Diseases|February 22, 2012
Genetically associated CD16(+)56(-) natural killer cell interferon (IFN)-αR expression regulates signaling and is implicated in IFN-α-induced hepatitis C virus declineSara J Conry, Qinglai Meng, Gareth Hardy, et al.
Nature Structural & Molecular Biology|August 10, 2010
Mycobacterium tuberculosis lipoprotein LprG (Rv1411c) binds triacylated glycolipid agonists of Toll-like receptor 2Michael G Drage, Han-Chun Tsai, Nicole D Pecora, et al.
European Journal of Immunology|February 6, 2014
TLR2 engagement on CD4(+) T cells enhances effector functions and protective responses to Mycobacterium tuberculosisScott M Reba, Qing Li, Sophia Onwuzulike, et al.
Plos One|February 1, 2012
Interferon-alpha administration enhances CD8+ T cell activation in HIV infectionMaura Manion, Benigno Rodriguez, Kathleen Medvik, et al.
Circulation Research|April 15, 2021
COVID-19 and Cardiovascular Disease: From Bench to BedsideMina K Chung, David A Zidar, Michael R Bristow, et al.
Plos One|February 26, 2013
Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markersGareth A D Hardy, Scott Sieg, Benigno Rodriguez, et al.
Infection and Immunity|April 20, 2006
The mycobacterial 38-kilodalton glycolipoprotein antigen activates the mitogen-activated protein kinase pathway and release of proinflammatory cytokines through Toll-like receptors 2 and 4 in human monocytesSaet-Byel Jung, Chul-Su Yang, Ji-Sook Lee, et al.
Pageof 12